Veterinary In Vitro Fertilization Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents/Consumables, Services), By Animal (Bovine, Swine), By Technique (Artificial Insemination, Embryo Transfer), By End Use, By Region, And Segment
Description
Veterinary In Vitro Fertilization Market Summary
The global veterinary in vitro fertilization market size was estimated at USD 1.82 billion in 2024 and is projected to reach USD 3.60 billion by 2033, growing at a CAGR of 8.04% from 2025 to 2033. The market is experiencing growth driven by rising demand for genetically superior livestock, increasing adoption of advanced reproductive technologies in cattle, equine, and exotic species, and government initiatives supporting animal breeding and conservation programs, which collectively enhance productivity and biodiversity.
The veterinary in vitro fertilization (IVF) industry is being significantly driven by technological advancements and the launch of more affordable products. For instance, in September 2024, Indian Immunologicals Limited, in collaboration with the National Dairy Development Board (NDDB), developed “Shashthi,” an indigenous IVF media, which has reduced the cost per embryo by 33% compared to imported media and has enhanced accessibility for farmers. Innovations such as Ovum Pick Up (OPU) and In Vitro Embryo Production (IVEP) are replacing traditional in vivo techniques, improving embryo quality and genetic multiplication in livestock. These advancements, coupled with the availability of cost-effective IVF solutions, are accelerating adoption across veterinary hospitals and fertility clinics, boosting productivity and fostering widespread acceptance of assisted reproductive technologies.
In addition, expanding the scope of IVF beyond livestock and companion animals into wildlife conservation is expected to boost market demand. It is also expected to drive increased investment, innovation, and cross-disciplinary research in veterinary reproductive technologies, solidifying IVF’s role in species preservation and global biodiversity initiatives. For instance, in January 2024, Scientists from the BioRescue consortium, led by Germany’s Leibniz Institute for Zoo and Wildlife Research, achieved the world’s first successful embryo transfer in southern white rhinos - a major milestone toward saving the nearly extinct northern white rhino. Using IVF, embryos created from preserved sperm and eggs are now stored in Germany and Italy, with plans to implant the first northern white rhino embryo into a surrogate in Kenya. Though the initial pregnancy ended prematurely, the achievement proves that rhino IVF and embryo transfer can work, marking a breakthrough in large-mammal reproduction science.
Global Veterinary In Vitro Fertilization Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary in vitro fertilization market report based on product, animal, technique, end use, and region.
The global veterinary in vitro fertilization market size was estimated at USD 1.82 billion in 2024 and is projected to reach USD 3.60 billion by 2033, growing at a CAGR of 8.04% from 2025 to 2033. The market is experiencing growth driven by rising demand for genetically superior livestock, increasing adoption of advanced reproductive technologies in cattle, equine, and exotic species, and government initiatives supporting animal breeding and conservation programs, which collectively enhance productivity and biodiversity.
The veterinary in vitro fertilization (IVF) industry is being significantly driven by technological advancements and the launch of more affordable products. For instance, in September 2024, Indian Immunologicals Limited, in collaboration with the National Dairy Development Board (NDDB), developed “Shashthi,” an indigenous IVF media, which has reduced the cost per embryo by 33% compared to imported media and has enhanced accessibility for farmers. Innovations such as Ovum Pick Up (OPU) and In Vitro Embryo Production (IVEP) are replacing traditional in vivo techniques, improving embryo quality and genetic multiplication in livestock. These advancements, coupled with the availability of cost-effective IVF solutions, are accelerating adoption across veterinary hospitals and fertility clinics, boosting productivity and fostering widespread acceptance of assisted reproductive technologies.
In addition, expanding the scope of IVF beyond livestock and companion animals into wildlife conservation is expected to boost market demand. It is also expected to drive increased investment, innovation, and cross-disciplinary research in veterinary reproductive technologies, solidifying IVF’s role in species preservation and global biodiversity initiatives. For instance, in January 2024, Scientists from the BioRescue consortium, led by Germany’s Leibniz Institute for Zoo and Wildlife Research, achieved the world’s first successful embryo transfer in southern white rhinos - a major milestone toward saving the nearly extinct northern white rhino. Using IVF, embryos created from preserved sperm and eggs are now stored in Germany and Italy, with plans to implant the first northern white rhino embryo into a surrogate in Kenya. Though the initial pregnancy ended prematurely, the achievement proves that rhino IVF and embryo transfer can work, marking a breakthrough in large-mammal reproduction science.
Global Veterinary In Vitro Fertilization Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary in vitro fertilization market report based on product, animal, technique, end use, and region.
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Instruments
- Reagents/Consumables
- Services
- Animal Outlook (Revenue, USD Million, 2021 - 2033)
- Bovine
- Swine
- Ovine
- Caprine
- Equine
- Other Animals
- Technique Outlook (Revenue, USD Million, 2021 - 2033)
- Artificial Insemination
- Embryo Transfer
- Ovum Pickup
- In-Vitro Maturation
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Veterinary Fertility Clinics
- Veterinary Hospitals
- Research Laboratories
- Cryobanks
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Netherlands
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Kuwait
- Qatar
- Oman
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Animal
- 1.2.3. Technique
- 1.2.4. End Use
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR’s Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.5. Information/Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Model 1: Bottom-Up Analysis
- 1.7.2. Model 2: Volume-Pricing Analysis
- 1.7.3. Model 3: Commodity Flow Analysis
- 1.8. List of Secondary Sources
- 1.9. List of Abbreviations
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- Chapter 3. Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary/Related Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing demand for meat, dairy, and animal protein products.
- 3.2.1.2. Rising demand for advanced reproductive technologies in animal breeding
- 3.2.1.3. Technological advancements in IVF techniques
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of veterinary IVF services
- 3.2.2.2. Regulatory, ethical and skilled-personnel challenges.
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Pricing Analysis
- 3.4. Market Analysis Tools
- 3.4.1. Porter’s Five Forces Analysis
- 3.4.2. PESTEL by SWOT Analysis
- Chapter 4. Veterinary In Vitro Fertilization Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Veterinary In Vitro Fertilization Market, By Product Movement Analysis
- 4.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
- 4.4. Instruments
- 4.4.1. Instruments Market Estimates and Forecasts, 2021-2033 (USD Million)
- 4.5. Reagents/Consumables
- 4.5.1. Reagents/Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Services
- 4.6.1. Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Veterinary In Vitro Fertilization Market: Animal Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Veterinary In Vitro Fertilization Market, By Animal Movement Analysis
- 5.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
- 5.4. Bovine
- 5.4.1. Bovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Swine
- 5.5.1. Swine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Ovine
- 5.6.1. Ovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Caprine
- 5.7.1. Caprine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Equine
- 5.8.1. Equine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Others Animals
- 5.9.1. Others Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Veterinary In Vitro Fertilization Market: By Technique Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Veterinary In Vitro Fertilization Market, By Technique Movement Analysis
- 6.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, By Technique, 2021 to 2033 (USD Million)
- 6.4. Artificial Insemination
- 6.4.1. Artificial Insemination Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Embryo Transfer
- 6.5.1. Embryo Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Ovum Pickup
- 6.6.1. Ovum Pickup Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. In-Vitro Maturation
- 6.7.1. In-Vitro Maturation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Veterinary In Vitro Fertilization Market: By End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Veterinary In Vitro Fertilization Market, By End Use Movement Analysis
- 7.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
- 7.3.1. Veterinary Fertility Clinics
- 7.3.1.1. Veterinary Fertility Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. Veterinary Hospitals
- 7.3.2.1. Veterinary Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Research Laboratories
- 7.3.3.1. Research Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Cryobanks
- 7.3.4.1. Cryobanks Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.5. Others
- 7.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Veterinary In Vitro Fertilization Market: By Regional Estimates & Trend Analysis
- 8.1. Region Market Dashboard
- 8.2. Region Market Share Analysis, 2024 & 2033
- 8.3. North America
- 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. U.S
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4. Europe
- 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.2. UK
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.3. Germany
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.7. Netherlands
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. Netherlands Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.8. Denmark
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Competitive Scenario
- 8.4.8.3. Regulatory Framework
- 8.4.8.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.9. Sweden
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Competitive Scenario
- 8.4.9.3. Regulatory Framework
- 8.4.9.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.10. Norway
- 8.4.10.1. Key Country Dynamics
- 8.4.10.2. Competitive Scenario
- 8.4.10.3. Regulatory Framework
- 8.4.10.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.3. China
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.5. Australia
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competitive Scenario
- 8.5.5.3. Regulatory Framework
- 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.6. Thailand
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Competitive Scenario
- 8.5.6.3. Regulatory Framework
- 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.7. South Korea
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Scenario
- 8.5.7.3. Regulatory Framework
- 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7. MEA
- 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.3. UAE
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.4. Saudi Arabia
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory Framework
- 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Competitive Scenario
- 8.7.5.3. Regulatory Framework
- 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.6. Qatar
- 8.7.6.1. Key Country Dynamics
- 8.7.6.2. Competitive Scenario
- 8.7.6.3. Regulatory Framework
- 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.7. Oman
- 8.7.7.1. Key Country Dynamics
- 8.7.7.2. Competitive Scenario
- 8.7.7.3. Regulatory Framework
- 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.1.1. Market Leaders
- 9.1.2. Emerging Players
- 9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
- 9.3. Company Profiles
- 9.3.1. Zoetis Services LLC
- 9.3.1.1. Participant’s Overview
- 9.3.1.2. Financial Performance
- 9.3.1.3. Product/Service Benchmarking
- 9.3.1.4. Strategic Initiatives
- 9.3.2. Kruuse
- 9.3.2.1. Participant’s Overview
- 9.3.2.2. Financial Performance
- 9.3.2.3. Product/Service Benchmarking
- 9.3.2.4. Strategic Initiatives
- 9.3.3. Hamilton Thorne, Inc.
- 9.3.3.1. Participant’s Overview
- 9.3.3.2. Financial Performance
- 9.3.3.3. Product/Service Benchmarking
- 9.3.3.4. Strategic Initiatives
- 9.3.4. Esco Medical
- 9.3.4.1. Participant’s Overview
- 9.3.4.2. Financial Performance
- 9.3.4.3. Product/Service Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. Imy Technologies
- 9.3.5.1. Participant’s Overview
- 9.3.5.2. Financial Performance
- 9.3.5.3. Product/Service Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. Minitube
- 9.3.6.1. Participant’s Overview
- 9.3.6.2. Financial Performance
- 9.3.6.3. Product/Service Benchmarking
- 9.3.6.4. Strategic Initiatives
- 9.3.7. Agetech Inc.
- 9.3.7.1. Participant’s Overview
- 9.3.7.2. Financial Performance
- 9.3.7.3. Product/Service Benchmarking
- 9.3.7.4. Strategic Initiatives
- 9.3.8. Orgensen Laboratories
- 9.3.8.1. Participant’s Overview
- 9.3.8.2. Financial Performance
- 9.3.8.3. Product/Service Benchmarking
- 9.3.8.4. Strategic Initiatives
- 9.3.9. Bovine Elite LLC
- 9.3.9.1. Participant’s Overview
- 9.3.9.2. Financial Performance
- 9.3.9.3. Product/Service Benchmarking
- 9.3.9.4. Strategic Initiatives
- 9.3.10. Equine Fertility Centre
- 9.3.10.1. Participant’s Overview
- 9.3.10.2. Financial Performance
- 9.3.10.3. Product/Service Benchmarking
- 9.3.10.4. Strategic Initiatives
- 9.3.11. Veterinary Group
- 9.3.11.1. Participant’s Overview
- 9.3.11.2. Financial Performance
- 9.3.11.3. Product/Service Benchmarking
- 9.3.11.4. Strategic Initiatives
- 9.3.12. Stateline Veterinary Service
- 9.3.12.1. Participant’s Overview
- 9.3.12.2. Financial Performance
- 9.3.12.3. Product/Service Benchmarking
- 9.3.12.4. Strategic Initiatives
- 9.4. List of other key players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
